Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | meticrane | 4165 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | meticrane | 4165 | drug-path |
| Apoptosis | R-HSA-109581 | map04210 | meticrane | 4165 | drug-path |
| Acute myeloid leukemia | R-HSA-9680350 | map05221 | meticrane | 4165 | drug-path |
| Vibrio cholerae infection | R-HSA-9609646 | map05110 | meticrane | 4165 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | meticrane | 4165 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | meticrane | 4165 | drug-path |
| SNARE interactions in vesicular transport | R-HSA-428625 | map04130 | sulfaphenazole | 5335 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | sulfaphenazole | 5335 | drug-path |
| Renal cell carcinoma | R-HSA-9794523 | map05211 | sulfaphenazole | 5335 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | sulfaphenazole | 5335 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | sulfaphenazole | 5335 | drug-path |
| Shigellosis | 0 | map05131 | sulfaphenazole | 5335 | drug-path |
| Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | sulfaphenazole | 5335 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | sulfaphenazole | 5335 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | sulfaphenazole | 5335 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | sulfaphenazole | 5335 | drug-path |
| Endometrial cancer | R-HSA-2077421 | map05213 | sulfaphenazole | 5335 | drug-path |
| Axon guidance | R-HSA-422475 | map04360 | procaine | 4914 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | procaine | 4914 | drug-path |